HER2 positivity may confer resistance to therapy with paclitaxel in breast cancer cell lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HER2 positivity may confer resistance to therapy with paclitaxel in breast cancer cell lines

Published:2017-05-16 Issue:3 Volume:46 Page:518-523
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Haghnavaz Navideh¹²³,Asghari Faezeh¹²,Elieh Ali Komi Daniel¹²,Shanehbandi Dariush²,Baradaran Behzad¹²,Kazemi Tohid¹²

Affiliation:

1. Immunology Research Center, Tabriz University of Medical Science, Tabriz, Iran;

2. Department of Immunology, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran;

3. Student research committee, Tabriz University of Medical Science, Tabriz, Iran

Funder

Immunology Research Center, Tabriz University of Medical Sciences

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2017.1326927

Reference42 articles.

1. MicroRNAs and their target gene networks in breast cancer

2. miRNA genetic alterations in human cancers

3. The Role of MicroRNAs in Breast Cancer Migration, Invasion and Metastasis

4. MicroRNA involvement in the pathogenesis and management of breast cancer

5. MicroRNA Signatures in Human Ovarian Cancer

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential effects of docosahexaenoic acid (DHA) and linoleic acid (LA) on miR-101 and miR-342 tumor suppressor microRNAs in Taxol-treated HER2-positive breast cancer cells;Clinical Nutrition ESPEN;2024-10

2. Slow Sulfide Donor GYY4137 Increased the Sensitivity of Two Breast Cancer Cell Lines to Paclitaxel by Different Mechanisms;Biomolecules;2024-05-31

3. Trastuzumab-conjugated liposomes for co-delivery of paclitaxel and anti-abcb1 siRNA in HER2-positive breast cancer: In vitro and in vivo evaluations;Journal of Drug Delivery Science and Technology;2024-05

4. Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice;Medicina;2024-01-17

5. Biosynthesis of anticancer phytochemical compounds and their chemistry;Frontiers in Pharmacology;2023-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3